UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipoid pneumonia mimicking multifocal lung cancer in a patient with a remote laryngectomy and a recently diagnosed lung cancer: PET/CT findings

Lung cancer (Amsterdam, Netherlands), 2018-02, Vol.116, p.99-101

2018

Volltextzugriff (PDF)

Lung cancer with retrograde extension into the right main pulmonary artery: Positron emission tomography/computed tomography findings

Surgery, 2018-02, Vol.163 (2), p.476-477

2018

Volltextzugriff (PDF)

Nivolumab-induced pneumonitis complicated by cyst formation

Lung cancer (Amsterdam, Netherlands), 2018-08, Vol.122, p.258-259

2018

Volltextzugriff (PDF)

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Journal of clinical medicine, 2022-06, Vol.11 (11), p.3245

2022

Volltextzugriff (PDF)

Recommendations of the Spanish Society of Pneumology and Thoracic Surgery on the diagnosis and treatment of non-small-cell lung cancer

Archivos de bronconeumología (English ed.), 2016-05, Vol.52 Suppl 1, p.2-62

2016

Volltextzugriff (PDF)

Primary Mediastinal Germ Cell Tumor Containing an Angiosarcomatous Component

The Annals of thoracic surgery, 2016-07, Vol.102 (1), p.e63-e63

2016

Volltextzugriff (PDF)

Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab

Current problems in cancer. Case reports, 2022-03, Vol.5, p.100145, Article 100145

2022

Volltextzugriff (PDF)

ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors

Current problems in cancer. Case reports, 2021-12, Vol.4, p.100124, Article 100124

2021

Volltextzugriff (PDF)

Lung Cancer in a Patient With Lymphangioleiomyomatosis

Archivos de bronconeumología (English ed.), 2017-06, Vol.53 (6), p.342-342

2017

Volltextzugriff (PDF)

Development of Thyroid Carcinoma During Treatment With Pembrolizumab in a Lung Cancer Patient

The Annals of thoracic surgery, 2020-06, Vol.109 (6), p.e397-e399

2020

Volltextzugriff (PDF)

Targeting KRAS in Non-Small Cell Lung Cancer

Frontiers in oncology, 2022-01, Vol.11, p.792635-792635

2022

Volltextzugriff (PDF)

Metastasis to the corpus spongiosum of the penis in a patient with lung cancer causing acute urine retention

Surgery, 2018-02, Vol.163 (2), p.474-475

2018

Volltextzugriff (PDF)

Carcinoma broncogénico en paciente con linfangioleiomiomatosis

Archivos de bronconeumología, 2017-06, Vol.53 (6), p.342-342

2017

Volltextzugriff (PDF)

NUT midline carcinoma causing critical stenosis of the coronary arteries: CT demonstration

Surgery, 2018-02, Vol.163 (2), p.480-481

2018

Volltextzugriff (PDF)

Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report

Translational lung cancer research, 2022-07, Vol.11 (7), p.1497-1502

2022

Volltextzugriff (PDF)

Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer

Archivos de bronconeumología (English ed.), 2016-07, Vol.52 (7), p.378-388

2016

Volltextzugriff (PDF)

Sumario ejecutivo de las recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

Archivos de bronconeumología, 2016-07, Vol.52 (7), p.378-388

2016

Volltextzugriff (PDF)

Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

Archivos de bronconeumología (English ed.), 2016-05, Vol.52, p.2-62

2016

Volltextzugriff (PDF)

Clinical, pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer: A multicenter experience in Madrid

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21128-e21128

2018

Volltextzugriff (PDF)

Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, in patients with non-small cell lung cancer (NSCLC): Interim data from a phase I dose escalation and NSCLC expansion cohort

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.116-116

2019

Volltextzugriff (PDF)

Clinical, pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer in a multicenter experience in Madrid: Final results

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20621-e20621

2019

Volltextzugriff (PDF)

Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, in patients with non-small cell lung cancer (NSCLC): Interim data from phase 1 dose escalation and NSCLC Expansion Cohort

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21057-e21057

2018

Volltextzugriff (PDF)

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8506-8506

2019

Volltextzugriff (PDF)

Lung cancer in a patient with lymphangioleiomyomatosis

Archivos de bronconeumologia, 2017, Vol.53 (6), p.342-342

2017

Volltextzugriff (PDF)

Lurbinectedin (PM01183) with doxorubicin (DOX), an active treatment as second-line therapy in small cell lung cancer (SCLC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7509-7509

2015

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(41)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lipoid pneumonia mimicking multifocal lung cancer in a patient with a remote laryngectomy and a recently diagnosed lung cancer: PET/CT findings

Lung cancer with retrograde extension into the right main pulmonary artery: Positron emission tomography/computed tomography findings

Nivolumab-induced pneumonitis complicated by cyst formation

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Recommendations of the Spanish Society of Pneumology and Thoracic Surgery on the diagnosis and treatment of non-small-cell lung cancer

Primary Mediastinal Germ Cell Tumor Containing an Angiosarcomatous Component

Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab

ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors

Lung Cancer in a Patient With Lymphangioleiomyomatosis

Development of Thyroid Carcinoma During Treatment With Pembrolizumab in a Lung Cancer Patient

Targeting KRAS in Non-Small Cell Lung Cancer

Metastasis to the corpus spongiosum of the penis in a patient with lung cancer causing acute urine retention

Carcinoma broncogénico en paciente con linfangioleiomiomatosis

NUT midline carcinoma causing critical stenosis of the coronary arteries: CT demonstration

Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report

Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer

Sumario ejecutivo de las recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

Clinical, pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer: A multicenter experience in Madrid

Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, in patients with non-small cell lung cancer (NSCLC): Interim data from a phase I dose escalation and NSCLC expansion cohort

Clinical, pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer in a multicenter experience in Madrid: Final results

Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, in patients with non-small cell lung cancer (NSCLC): Interim data from phase 1 dose escalation and NSCLC Expansion Cohort

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

Lung cancer in a patient with lymphangioleiomyomatosis

Lurbinectedin (PM01183) with doxorubicin (DOX), an active treatment as second-line therapy in small cell lung cancer (SCLC)

Suchergebnisse filtern